These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 25024136)

  • 21. Card9-dependent IL-1β regulates IL-22 production from group 3 innate lymphoid cells and promotes colitis-associated cancer.
    Bergmann H; Roth S; Pechloff K; Kiss EA; Kuhn S; Heikenwälder M; Diefenbach A; Greten FR; Ruland J
    Eur J Immunol; 2017 Aug; 47(8):1342-1353. PubMed ID: 28586167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal macrophages arising from CCR2(+) monocytes control pathogen infection by activating innate lymphoid cells.
    Seo SU; Kuffa P; Kitamoto S; Nagao-Kitamoto H; Rousseau J; Kim YG; Núñez G; Kamada N
    Nat Commun; 2015 Aug; 6():8010. PubMed ID: 26269452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymopentin ameliorates dextran sulfate sodium-induced colitis by triggering the production of IL-22 in both innate and adaptive lymphocytes.
    Cao Q; Gao X; Lin Y; Yue C; Wang Y; Quan F; Zhang Z; Liu X; Lu Y; Zhan Y; Yang H; Li X; Qin D; Birnbaumer L; Hao K; Yang Y
    Theranostics; 2019; 9(25):7490-7505. PubMed ID: 31695782
    [No Abstract]   [Full Text] [Related]  

  • 24. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
    Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
    Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cell surface receptor Slamf6 modulates innate immune responses during Citrobacter rodentium-induced colitis.
    van Driel B; Wang G; Liao G; Halibozek PJ; Keszei M; O'Keeffe MS; Bhan AK; Wang N; Terhorst C
    Int Immunol; 2015 Sep; 27(9):447-57. PubMed ID: 25957267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-18-induced HIF-1α in ILC3s ameliorates the inflammation of C. rodentium-induced colitis.
    Valle-Noguera A; Sancho-Temiño L; Castillo-González R; Villa-Gómez C; Gomez-Sánchez MJ; Ochoa-Ramos A; Yagüe-Fernández P; Soler Palacios B; Zorita V; Raposo-Ponce B; González-Granado JM; Aragonés J; Cruz-Adalia A
    Cell Rep; 2023 Dec; 42(12):113508. PubMed ID: 38019650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium.
    Lebeis SL; Powell KR; Merlin D; Sherman MA; Kalman D
    Infect Immun; 2009 Feb; 77(2):604-14. PubMed ID: 19075023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Citrobacter rodentium-induced colitis: A robust model to study mucosal immune responses in the gut.
    Koroleva EP; Halperin S; Gubernatorova EO; Macho-Fernandez E; Spencer CM; Tumanov AV
    J Immunol Methods; 2015 Jun; 421():61-72. PubMed ID: 25702536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D Is Required for ILC3 Derived IL-22 and Protection From
    Lin YD; Arora J; Diehl K; Bora SA; Cantorna MT
    Front Immunol; 2019; 10():1. PubMed ID: 30723466
    [No Abstract]   [Full Text] [Related]  

  • 30. Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms.
    Castleman MJ; Dillon SM; Purba CM; Cogswell AC; Kibbie JJ; McCarter MD; Santiago ML; Barker E; Wilson CC
    Front Immunol; 2019; 10():649. PubMed ID: 30984202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OLFM4 modulates intestinal inflammation by promoting IL-22
    Xing Z; Li X; He J; Chen Y; Zhu L; Zhang X; Huang Z; Tang J; Guo Y; He Y
    Commun Biol; 2024 Jul; 7(1):914. PubMed ID: 39075283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Nutrient-sensing Receptor GPRC6A in Regulating Colonic Group 3 Innate Lymphoid Cells and Inflamed Mucosal Healing.
    Hou Q; Huang J; Xiong X; Guo Y; Zhang B
    J Crohns Colitis; 2022 Aug; 16(8):1293-1305. PubMed ID: 35134872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-21 Controls ILC3 Cytokine Production and Promotes a Protective Phenotype in a Mouse Model of Colitis.
    Poholek CH; Dulson SJ; Zajac AJ; Harrington LE
    Immunohorizons; 2019 Jun; 3(6):194-202. PubMed ID: 31356165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes.
    Stojanović I; Saksida T; Miljković Đ; Pejnović N
    Front Immunol; 2021; 12():653560. PubMed ID: 34149694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
    Valatas V; Kolios G; Bamias G
    Front Immunol; 2019; 10():583. PubMed ID: 30972074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct Kinase-Independent Role of RIPK3 in CD11c
    Moriwaki K; Balaji S; Bertin J; Gough PJ; Chan FK
    Cell Rep; 2017 Mar; 18(10):2441-2451. PubMed ID: 28273458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ILC3 function as a double-edged sword in inflammatory bowel diseases.
    Zeng B; Shi S; Ashworth G; Dong C; Liu J; Xing F
    Cell Death Dis; 2019 Apr; 10(4):315. PubMed ID: 30962426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity.
    Chun E; Lavoie S; Fonseca-Pereira D; Bae S; Michaud M; Hoveyda HR; Fraser GL; Gallini Comeau CA; Glickman JN; Fuller MH; Layden BT; Garrett WS
    Immunity; 2019 Nov; 51(5):871-884.e6. PubMed ID: 31628054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice.
    Sokol H; Conway KL; Zhang M; Choi M; Morin B; Cao Z; Villablanca EJ; Li C; Wijmenga C; Yun SH; Shi HN; Xavier RJ
    Gastroenterology; 2013 Sep; 145(3):591-601.e3. PubMed ID: 23732773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT3 activation in Th17 and Th22 cells controls IL-22-mediated epithelial host defense during infectious colitis.
    Backert I; Koralov SB; Wirtz S; Kitowski V; Billmeier U; Martini E; Hofmann K; Hildner K; Wittkopf N; Brecht K; Waldner M; Rajewsky K; Neurath MF; Becker C; Neufert C
    J Immunol; 2014 Oct; 193(7):3779-91. PubMed ID: 25187663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.